BMC Cancer

Table 2 Immunohistochemical staining results of ER/PR/HER2, CK5/6, and EGFR

From: Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

		ER			PR			HER2			CK5			EGFR
Case	Intensity	Location	Percent	Intensity	Location	Percent	Intensity	Location	Percent	Intensity	Location	Percent	Intensity	Location	Percent
1			0	1	N*	5			0	3	M, C*	100			0
2			0			0			0	3	*M, C*	*100*			0
3			0			0	2	C, M	20	3	M	20	2	C, M	80
4	1	N	40			0	2	M	20	3	M	100	2	M	15
5	1	N	10			0			0	3	M	30	2	M	50
6			0			0			0	3	*C, M*	40	1	M	5
7			0			0			0	3	*M, C*	80	1	M	60
8			0			0			0			0			0
9			0			0			0	3	*C, M*	25	1	*C, M*	30
10			0	1	N	5			0	3	C, M	5	1	C	10
11			0	3	N	90			0			0			0
12			0	2	N	80			0			0	1	M	5
13			0	1	N	10	2	C, M	40	3	M	80	1	M, C	15
14			0			0			0	3	M	*100*			0
15			0			0			0	3	*M, C*	70	1	*C, M*	30
16			0	1	N	30			0	3	M	50	2	C, M	50
17			0			0			0			0	2	*M, C*	30
18			0			0			0			0			0
19			0			0			0	3	*M, C*	90	2	M	90
20			0			0			0	3	M	90	1	M	80
21			0	1	N	5	2	M	30			0			0
22			0			0			0	3	M	20	1	*C, M*	70
23			0			0			0			0			0
24			0			0			0	3	M	70			0

*N nuclear, C cytoplasmic, M membranous.
Feline triple-negative, basal-like adenocarcinomas (case numbers 2, 6, 7, 9, 14, 15, 17, 19, 20, 22, 24 in italicized boldface) were submitted for genetic analysis.

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com